The Executive Medical Director, Hematology, will provide overall clinical scientific leadership for the cell therapy program and have responsibility for our clinical development strategy and execution of clinical trials in this area. This role will be a key partner with the Global Program Head to design the optimal development strategy for this portfolio. This role requires an impactful and highly hard‑working individual who serves as a clinical role model for the team and demonstrates outstanding clinical scientific knowledge applicable to hematology clinical research. The Executive Medical Director, Hematology reports directly to the VP, Therapeutic Area Lead, Hematology. Typical Day Acts as medical expert and leader in interactions with external collaborators (e.g., regulatory authorities, key opinion leaders, advisory boards, patient advocacy groups), internal collaborators (e.g., Research, Early Clinical Development, Global Medical Affairs, Marketing, HEOR), and internal decision boards. Uses excellent scientific standing among peers and the ability to address issues with scientific rigor and creative solutions. Uses this creativity and knowledge to easily build and defend data‑driven plans and decisions, both with internal scientific management and the Company’s partners / collaborators. Develops unique and innovative clinical strategies to significantly shorten the development cycle in the face of an evolving regulatory landscape. Designs and develops smaller, yet robust and innovative FIH as well as Phase 2/3 programs. Drives strong consensus‐building skills and the ability to lead multidisciplinary teams towards sound decision‑making. Leads dynamic and matrixed clinical teams in a fast‑paced and hands‑on environment. Leads and develops a team of MDs and clinical scientists to meet personal and business needs. Qualifications Demonstrated consistent track record in leadership roles that include working with senior clinical development staff, establishing credibility with external collaborators such as opinion leaders and regulators, and demonstrating substantial experience in drug development (including experience with both IND and BLA/NDA submission). Experience in leading study start‑up, directing and guiding study team execution, data cleaning, medical review, database locks, and handling health authority responses. A strong commitment to impacting patients through drug development and the ability to work well within a team setting are critical. Education & Experience Requirements In order to be considered for this position, you must have an advanced degree in medicine (MD or equivalent), with a MD/PhD strongly preferred. Specialized fellowship training in Hematology or Oncology is preferred. The incumbent will have a minimum of 6‑8 years of industry experience in related therapeutic area clinical development. Cell therapy drug development experience is preferred. People management experience is a plus. Location & On‑Site Requirements This role requires a minimum of 4 days on‑site weekly in Tarrytown, NY or Warren, NJ. Benefits We have an inclusive culture that provides comprehensive benefits, which vary by location. In the U.S., benefits may include health and wellness programs (including medical, dental, vision, life, and disability insurance), fitness centers, 401(k) company match, family support benefits, equity awards, annual bonuses, paid time off, and paid leaves (e.g., military and parental leave) for eligible employees at all levels. For additional information about Regeneron benefits in the U.S., please visit Equal Employment Opportunity Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. The Company will also provide reasonable accommodation to the known disabilities or chronic illnesses of an otherwise qualified applicant for employment, unless the accommodation would impose undue hardship on the operation of the Company’s business. Compensation $390,000.00 - $527,600.00 #J-18808-Ljbffr